Baili

Valink Therapeutics

Valink Therapeutics develops next-generation bispecific antibody-drug conjugates to treat solid tumours for cancer patients.

CrossBridge Bio

This company develops dual-payload antibody-drug conjugates to treat solid tumors for healthcare providers and pharmaceutical partners.

Alphina Therapeutics

This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.

Callio Therapeutics

The company develops multi-payload antibody-drug conjugates to treat cancer patients.

Profound Bio

This clinical-stage biotechnology company develops antibody-drug conjugates and targeted therapies for patients with solid tumors and hematological malignancies.

Clinical stage immunotherapy company

This company develops next-generation antibody-drug conjugates to treat patients with solid tumor malignancies.

Mersana Therapeutics

This company develops antibody-drug conjugates to treat various cancers for healthcare providers and patients within the oncology sector.

SELECXINE

Selecxine develops antibody-cytokine conjugates for cancer treatment, providing these immunotherapeutic biologics to the pharmaceutical industry and clinical research institutions.